Electrophysiology devices market

Electrophysiology Devices Market, by Product Type (Electrophysiology Monitoring Devices (Electrocardiograph, Holter Monitoring Devices, X-Ray Systems, Combo systems- Imaging and 3D mapping systems, Diagnostic Electrophysiology Catheters) Electrophysiology Treatment Devices (Implantable Cardioveter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Catheters)), by Indication (Atrial Fibrillation, Atrioventricular Nodal Re-entry Tachycardia, Supraventricular Tachycardia, Bradycardia, Others (Wolff-Parkinson-White Syndrome, etc.)) by End User (Hospitals, Diagnostic Centers, Clinics, and Others (Ambulatory Surgical Centers, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Dec 2022
CMI1641
145 Pages
Excel & Pdf
Medical Devices

Summary

Electrophysiology devices are medical devices that are used to diagnose arrhythmias and atrial fibrillation. Atrial fibrillation is arrhythmia where the chambers of the heart begin to rapidly beat. An electrophysiology study is a test performed to assess heart's electrical system or activity and is used to diagnose abnormal heartbeats or arrhythmia.The test is performed by inserting catheters and then wire electrodes, which measure electrical activity, through blood vessels that enter the heart.

The global electrophysiology devices market is estimated to be valued at US$ 7,756.5 million in 2022 and is expected to exhibit a CAGR of 12.6% during the forecast period (2022-2030).

Figure 1. Global Electrophysiology Devices Market Share (%), by Product Type, 2022

Global Electrophysiology Devices Market - Drivers

Increasing adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global electrophysiology devices market growth over the forecast period. For instance, in June 2021, Medtronic, a medical device company, announced that they had launched Micra AV, a miniaturized, fully self-contained pacemaker that delivers advanced pacing technology to atrioventricular block patients through a minimally invasive approach.

Electrophysiology Devices Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 7,756.5 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	12.6%	2030 Value Projection:	US$ 20,069.2 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Electrophysiology Monitoring Devices (Electrocardiograph, Holter Monitoring Devices, X-Ray Systems, Combo systems - Imaging and 3D mapping systems, Diagnostic Electrophysiology Catheters), Electrophysiology Treatment Devices (Implantable Cardioveter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Catheters) By Indication: Atrial Fibrillation, Atrioventricular Nodal Re-entry Tachycardia, Supraventricular Tachycardia, Bradycardia, Others (Wolff-Parkinson-White Syndrome, etc.) By End User: Hospitals, Diagnostic Centers, Clinics, Others (Ambulatory Surgical Centers, etc.)
Companies covered:	General Electric Company, Biotricity, Medtronic, VivaQuant, Inc., Johnson & Johnson Services, Inc., AliveCor, Inc., Bittium, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Inc., Abbott, BIOTRONIK, Boston Scientific Corporation, MicroPort Scientific Corporation, Koninklijke Philips N.V., Siemens Healthcare GmbH, HeartSciences, anumana, Inc., and Omega Medical Imaging, LLC.
Growth Drivers:	Increasing adoption of inorganic strategies such as product launches by key market players
Restraints & Challenges:	Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration

Figure 2. Global Electrophysiology Devices Market Value (US$ Million), by Region, 2022

Global Electrophysiology Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global electrophysiology devices market. For instance, in November 2021, according to the data published in European Journal of Therapeutics, the number of electrophysiology procedures had decreased by 11.1% in Turkey. All consecutive electrophysiology procedures were analyzed in the unit of Turkey. Hence, it was concluded that COVID-19 pandemic significantly decreased the number of electrophysiology procedures.

Global Electrophysiology Devices Market: Key Developments

Increasing adoption of inorganic growth strategies such as product approval by regulatory authorities such as the U.S. Food and Drug Administration is expected to drive the global electrophysiology devices market over the forecast period. For instance, in July 2020, Abbott, a medical device company, announced that they had received an approval from the U.S. Food and Drug Administration for Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices are used for the patient5s with heart disorders having magnetic resonanace imaging (MRI) compatibility. Moreover, the new devices offer bluetooth technology and a new patient smartphone app for improved remote monitoring, allowing for increased patient-physician engagement and streamlined communications.

Global Electrophysiology Devices Market: Restraint

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market over the forecast period. For instance, in Feburary 2021, the U.S. Food and Drug Administration recalled a class I device EMBLEM S-ICD, a subcutaneous implantable cardioverter defibrillator, which was manufactured by Boston Scientific Corporation, a medical technology company. The device was recalled because the manufacturing process may allow moisture to get inside the defibrillator and cause a short-circuit when it tries to deliver high voltage shocks.

Global Electrophysiology Devices Market - Key Players

Major players operating in the global electrophysiology devices market include General Electric Company, Biotricity, Medtronic, VivaQuant, Inc., Johnson & Johnson Services, Inc., AliveCor, Inc., Bittium, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Inc., Abbott, BIOTRONIK, Boston Scientific Corporation, MicroPort Scientific Corporation, Koninklijke Philips N.V., Siemens Healthcare GmbH, HeartSciences, anumana, Inc., and Omega Medical Imaging, LLC.

Table of Content

Table of Contents

*Browse 35 market data tables and 33 figures on "Global Electrophysiology Devices Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global electrophysiology devices market during the forecast period (2022-2030)?

The global electrophysiology devices market is estimated to be valued at US$ 7,756.5 million in 2022 and is expected to exhibit a CAGR of 12.6% between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing adoption of inorganic growth strategies such as product launches by key market players are expected to drive the market.

Which is the leading product type segment in the market?

Electrophysiology monitoring devices is the leading product type segment in the market.

What are the key factors hampering the market?

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration are the major factors hampering the market.

Which are the major players operating in the market?

Major players operating in the market include General Electric Company, Biotricity, Medtronic, VivaQuant, Inc., Johnson & Johnson Services, Inc., AliveCor, Inc., Bittium, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Inc., Abbott, BIOTRONIK, Boston Scientific Corporation, MicroPort Scientific Corporation, Koninklijke Philips N.V., Siemens Healthcare GmbH, HeartSciences, anumana, Inc., and Omega Medical Imaging, LLC.